Tag: transcatheter aortic valve replacement

CABG, TAVR drive hospital revenue despite cost variations

Editor's Note Coronary artery bypass graft (CABG) surgery and transcatheter aortic valve replacement (TAVR) generate the highest overall financial returns for US hospitals, despite not being the most profitable per procedure, according to a February 13 report in Cardiovascular Business. The article covers an analysis of Medicare data, published in…

Read More

By: Matt Danford
February 14, 2025
Share

Surgeons risk losing ground as transcatheter tricuspid valve interventions rise

Editor’s Note At the Society of Thoracic Surgeons (STS) annual meeting, experts urged cardiac surgeons to become more engaged in tricuspid valve treatment before transcatheter options gain too much traction according to a January 26 report in MedPage Today. With new transcatheter devices gaining FDA approval and the Centers for…

Read More

By: Matt Danford
January 29, 2025
Share

Study: Transcatheter aortic valve replacement offers similar outcomes to surgical aortic valve replacement

Editor's Note The largest scale analysis so far available comparing surgical aortic valve replacement (SAVR) to longer-term percutaneous devices for transcatheter aortic valve replacement (TAVR) supports the comparable long-term safety and efficacy of the latter procedure. According to a May 15 report in Medical Xpress, the findings raise important considerations for valve…

Read More

By: Matt Danford
May 22, 2024
Share

Transcatheter therapy system becomes first to earn FDA approval for treating tricuspid regurgitation

Editor's Note Patients with severe cases of tricuspid regurgitation (in which a critical heart valve fails to close properly) now have a new treatment option thanks to the recent US Food and Drug Administration (FDA) approval of the ENVOQUE tricuspid valve replacement system, according to a February 2 press release…

Read More

By: Matt Danford
February 14, 2024
Share

Study: Redo TAVR procedures safe, effective

Editor's Note This study by researchers at Cedars-Sinai Medical Center, Los Angeles, finds that redo transcatheter aortic valve replacement (TAVR) procedures are both safe and effective. Of 350,591 patients in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry who underwent TAVR with balloon-expandable valves between November…

Read More

By: Judy Mathias
September 5, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat